GlassScriptPhysician profile
James L Newlon
NPI 1982785937
$2,463.27
in general payments reported to CMS, 2019-2025
16 companies · $948 in 2025
The $948 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $81.59 · 2021: $195 · 2022: $152 · 2023: $535 · 2024: $386 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,868.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $631.69 | 2021-2025 | Xeomin |
| Genzyme Corporation | $320.83 | 2023-2025 | |
| Glaxosmithkline, LLC. | $304.06 | 2021-2025 | Nucala |
| Stryker Corporation | $295.65 | 2019-2025 | Scopis Ent |
| Optinose US, INC. | $253.18 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $153.14 | 2024-2025 | Dupixent |
| Intuitive Surgical, INC. | $133.82 | 2025 | |
| Hill Dermaceuticals, INC. | $62.74 | 2025 | Tolak |
| Inspire Medical Systems, INC. | $58.70 | 2024-2025 | Inspire |
| Intersect Ent, INC. | $48.83 | 2019-2021 | |
| Integra Lifesciences Corporation | $46.70 | 2024 | Acclarent Aera |
| Merck Sharp & Dohme LLC | $45.04 | 2021-2023 | |
| Acclarent, INC | $37.27 | 2023 | Trudi Nav Cable |
| Medtronic USA, INC. | $30.95 | 2019 | |
| Baxter Healthcare | $21.29 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $19.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Newlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.